History
Australian indigenous communities have used the Melaleuca alternifolia species of the native tea tree shrub as a topical medical treatment for centuries due to its antiseptic properties.
There are over 130 species in the Melaleuca family of which five have been found to have beneficial properties and are used in the preparation of treatment oils, often referred to commercially as ‘tea tree oil’.
Melaleuca alternifolia oil holds the greatest number of beneficial properties of those available and has therefore been adopted as a natural skin treatment globally. However, due to its potential toxicity the ability to consume it has been limited until now.
In 2001, a team of Australian scientists led by renowned microbiologist Professor Max Reynolds set out to resolve this limitation. Conducting careful, extensive global research and clinical trials, the team worked to extract the bulk of the monoterpenes in the overall finished product, reducing its toxicity and harnessing tea tree oil’s high number of beneficial properties.
The outcome was 98alive™, a natural medicine that is listed on the Australian Register of Therapeutic Goods. |
